ADCT vs NI · rev $40.1M vs P/E 23, rev $3.61B
ADC Therapeutics SA (ADCT) versus NiSource Inc (NI) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
NiSource Inc (NI) is a utilities - regulated gas company listed on NYSE.
Latest reported ADCT revenue for 2026-06-30 was $40.1M. Net income was -$49.5M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. ADCT currently screens at market cap $141.2M.
Latest reported NI revenue for 2026-06-30 was $3.61B. Net income was $552.6M. Revenue was up 55.5% from 2026-03-31 to 2026-06-30. NI currently screens at market cap $22.42B and trailing P/E 23.3.
ADCT currently screens at market cap $141.2M. NI currently screens at market cap $22.42B and trailing P/E 23.3.
Not investment advice. Open the ADCT and NI stock pages for the full models.
Not investment advice.